Getagraph.com logo
S&P 500
(0.91%) 5 064.20 points
Dow Jones
(0.85%) 38 226 points
Nasdaq
(1.51%) 15 841 points
Oil
(0.08%) $79.06
Gas
(5.02%) $2.03
Gold
(0.10%) $2 313.40
Silver
(0.68%) $26.93
Platinum
(0.85%) $963.00
USD/EUR
(-0.07%) $0.932
USD/NOK
(-0.28%) $11.00
USD/GBP
(-0.07%) $0.798
USD/RUB
(-2.28%) $91.13

Realaus laiko atnaujinimai Codexis Inc [CDXS]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Biotechnology
Upcoming Earnings Alert

Quarter results today
(amc 2024-05-02)

Expected move: +/- 6.91%

BUY
100.00%
return 6.40%
SELL
75.00%
return 1.73%
Atnaujinta2 geg. 2024 @ 23:00
25% discount on Stockinvest.us - Use code: Podcast

7.40% $ 3.34

PARDAVIMAS 112739 min ago

@ $2.88

Išleistas: 14 vas. 2024 @ 16:31

Grąža: 16.01%

Ankstesnis signalas: vas. 13 - 16:30

Ankstesnis signalas: Pirkimas

Grąža: 0.67 %

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 23:00):
Profile picture for Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening...

Stats
Šios dienos apimtis 723 057
Vidutinė apimtis 571 567
Rinkos kapitalizacija 235.66M
EPS $0 ( 2024-02-28 )
Kita pelno data ( $-0.180 ) 2024-06-11
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.98
ATR14 $0.00600 (0.18%)
Insider Trading
Date Person Action Amount type
2024-01-01 Ryali Sriram Buy 314 125 Stock Option (Right to Buy)
2024-01-01 Ryali Sriram Buy 52 350 Common Stock
2024-01-01 Norrett Kevin Buy 314 125 Stock Option (Right to Buy)
2024-01-01 Norrett Kevin Buy 52 350 Common Stock
2024-01-01 Fitzgerald Margaret Nell Buy 314 125 Stock Option (Right to Buy)
INSIDER POWER
79.14
Last 93 transactions
Buy: 6 649 590 | Sell: 1 047 461

Tūris Koreliacija

Ilgas: 0.30 (neutral)
Trumpas: 0.28 (neutral)
Signal:(82.06) Neutral

Codexis Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
ZD0.978
SRTS0.967
LGHL0.958
NWL0.954
NMTR0.952
TBNK0.952
GDS0.95
MODV0.949
WMG0.949
TRIP0.948
10 Labiausiai neigiamai susiję koreliacijos
MTRY-0.947
AHRN-0.943
AFAR-0.94
FRSG-0.939
MCAA-0.938
TBSA-0.934
LEGA-0.933
CITE-0.932
NBSTU-0.931
MSDA-0.931

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Codexis Inc Koreliacija - Valiuta/Žaliavos

The country flag 0.34
( neutral )
The country flag 0.29
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.75
( moderate )
The country flag -0.14
( neutral )

Codexis Inc Finansinės ataskaitos

Annual 2023
Pajamos: $70.14M
Bruto pelnas: $51.82M (73.87 %)
EPS: $-1.120
FY 2023
Pajamos: $70.14M
Bruto pelnas: $51.82M (73.87 %)
EPS: $-1.120
FY 2022
Pajamos: $138.59M
Bruto pelnas: $100.56M (72.56 %)
EPS: $-0.510
FY 2021
Pajamos: $104.75M
Bruto pelnas: $82.55M (78.80 %)
EPS: $-0.330

Financial Reports:

No articles found.

Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.